Preparation, etude stereochimique et evaluation de l'activite antileucemique de derives glucosidiques du (-)-steganol

Journal of Natural Products

Volumn 48, Issue 3, 1985, Pages 345-356

  Houlbert, Nadine ^a   Brown, Eric ^a   Robin, Jean Pierre ^a   Davoust, Daniel ^b   Chiaroni, AngèLe ^b   Prangè, Thierry ^b   Riche, Claude ^b  

^a UNIVERSITÉ DU MAINE   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; NEW DRUG; PODOPHYLLOTOXIN; STEGANACIN; STEGANOL; STEGANOL 4',6' O ETHYLIDENE BETA D GLUCOPYRANOSIDE; STEGANOL 4',6' O THENYLIDENE BETA D GLUCOPYRANOSIDE; STEGANOL DERIVATIVE; STEGANOL DIMER; TENIPOSIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL MODEL; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; DRUG ANALYSIS; DRUG CYTOTOXICITY; DRUG IDENTIFICATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; INTOXICATION; LEUKEMIA; LEUKEMIA P 388; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STEREOCHEMISTRY; THERAPY; X RAY ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHEMISTRY; DEALKYLATION; GLUCOSIDES; LACTONES; LEUKEMIA, EXPERIMENTAL; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOLECULAR CONFORMATION; STEREOISOMERISM;

EID: 0021821508     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np50039a001     Document Type: Article

References (18)

1. I. Jardine, “Podophyllotoxins,” in: “Anticancer Agents Based on Natural Product Models,” Ed. par J.M. Cassady et J. Douros, chap. 9, New York: Academic Press, 1980, pp. 319-351.
2. C. Keller-Juslén, M. Kuhn et A. von Wartburg, J. Med. Chem., 14, 936 (1971).
3. R.W.J. Wang, L.I. Rebhun et S.M. Kupchan, Cancer Research, 37, 3071 (1977).
4. F. Zavala, D. Guénard, J.-P. Robin et E. Brown, J. Med. Chem., 23, 546 (1980).
5. J.-P. Robin, O. Gringore et E. Brown, Tetrahedron Lett., 2709 (1980).
6. M. Taafrout, F. Rouessac et J.-P. Robin, Tetrahedron Lett., 2983 (1983); M. Taafrout, F. Rouessac, J. P. Robin, R.P. Hicks et A.T. Sneden, J. Nat. Prod., 47, 600 (1984) et les références citées.
7. M. Suffness et J. Douros, Methods in Cancer Research, 16, 73 (1979).
8. C.F. Brewer, J.D. Loike, S.B. Horwitz, H. Sternlicht et W.J. Gensler, J. Med. Chem., 22, 215 (1979).
9. M. Taafrout, F. Rouessac et J.-P. Robin, Tetrahedron Lett., 197 (1983).
10. R.F. Cahn, C. Ingold et V. Prelog, Angew. Chem. Internat. Ed., 5, 385 (1966).
11. Y. J. Xing, Acta Cryst., A37, 642 (1981).
12. C. Riche, 7th European Crystallographic meeting, Jérusalem, 1982.
13. G. Germain, P. Main, M.M. Woolfson, Acta Cryst., A27, 368 (1971).
14. L'ensemble des coordonnées atomiques est déposé au “Cambridge Crystallographic Data Centre,” Cambridge University: Cambridge.
15. S.M. Kupchan, R.W. Britton, M.F. Ziegler, C.J. Gilmore, R.J. Restivo et R.F. Bryan, J. Am. Chem. Soc., 95, 1335 (1973).
16. C.M. McCloskey et G.H. Coleman, Org. Synth. Coll. Vol., 3, 434(1955).
17. G.M. Sheldrick, “SHELX76 Program for crystal structure determination,” University of Cambridge: Cambridge, 1976.
18. International Tables for X-Ray Crystallography, Vol. 4, Birmingham: Kynoch Press, 1974.